Drug Pipeline

Bleximenib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07223814 Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by… Acute Myeloid Leukemia Recruiting
NCT06852222 A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… Leukemia, Myeloid, Acute Recruiting
Phase 1/2
NCT04811560 A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) Acute Leukemia Recruiting
Phase 1
NCT07295951 A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia Acute Lymphoblastic Leukemia Recruiting
NCT05453903 A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies Leukemia, Myeloid, Acute Active, Not Recruiting
Sponsors Running Bleximenib Trials
Janssen Research & Development, LLC (4) Stichting Hemato-Oncologie voor Volwassenen Nederland (1)
Disease Areas
Leukemia (5) Acute Myeloid Leukemia (AML) (2) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Bleximenib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free